Evidence map›Paper›PMID 25854603›Full record

ArticleJournal of structural and functional genomics2015

Expression platforms for producing eukaryotic proteins: a comparison of E. coli cell-based and wheat germ cell-free synthesis, affinity and solubility tags, and cloning strategies.

David J Aceti, Craig A Bingman, Russell L Wrobel, Ronnie O Frederick, Shin-Ichi Makino, Karl W Nichols, Sarata C Sahu, Lai F Bergeman, Paul G Blommel, Claudia C Cornilescu and 11 more

Abstract read
In one paragraph

Article in Journal of structural and functional genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. X-ray diffraction analysis and in vitro characterization of the UAM2 protein from Oryza sativa.Acta crystallographica. Section F, Structural biology communications · 2017
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

David J AcetiThe Center for Eukaryotic Structural Genomics, Department of Biochemistry, University of Wisconsin at Madison, 433 Babcock Dr., Madison, WI, 53706, USA.
Craig A Bingman
Russell L Wrobel
Ronnie O Frederick
Shin-Ichi Makino
Karl W Nichols
Sarata C Sahu
Lai F Bergeman
Paul G Blommel
Claudia C Cornilescu
Katarzyna A Gromek
Kory D Seder
Soyoon Hwang
John G Primm
Grzegorz Sabat
Frank C Vojtik
Brian F Volkman
Zsolt Zolnai
George N Phillips
John L Markley
Brian G Fox
University of Wisconsin–Madison · USMedical College of Wisconsin · US

Funding

Center for Eukaryotic Structural GenomicsP50GM064598 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI MARKLEY, JOHN L · 2001 to 2004
$23.7M
Specialized Center for Eukaryotic Structural GenomicsU54GM074901 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 2005 to 2009
$18.9M
TR&D 3: TECHNOLOGY DEVELOPMENT FOR NMR STUDIES OF SMALL MOLECULES (METABOLOMICS, NATURAL PRODUCTS, METABOLITE-PROTEIN INTERACTIONS) pp.537-585 P41GM103399 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 2012 to 2019
$9.4M
Partnership for High-Throughput Enabled Biology of the Mitochondrial ProteomeU01GM094622 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 2010 to 2014
$7.8M
The Transmembrane Protein CenterU54GM094584 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 2010 to 2014
$4.6M
Enzyme Discovery for Natural Product BiosynthesisU01GM098248 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI PHILLIPS, GEORGE NEAL · 2011 to 2015
$2.8M
NIGMS NIH HHS P41 GM103399NIGMS NIH HHS P50 GM064598NIGMS NIH HHS P50 GM64598NIGMS NIH HHS U01 GM094622NIGMS NIH HHS U01 GM098248NIGMS NIH HHS U54 GM074901NIGMS NIH HHS U54 GM094584NIGMS NIH HHS U54GM094584
6 · The paper itself

Abstract

Vectors designed for protein production in Escherichia coli and by wheat germ cell-free translation were tested using 21 well-characterized eukaryotic proteins chosen to serve as controls within the context of a structural genomics pipeline. The controls were carried through cloning, small-scale expression trials, large-scale growth or synthesis, and purification. Successfully purified proteins were also subjected to either crystallization trials or (1)H-(15)N HSQC NMR analyses. Experiments evaluated: (1) the relative efficacy of restriction/ligation and recombinational cloning systems; (2) the value of maltose-binding protein (MBP) as a solubility enhancement tag; (3) the consequences of in vivo proteolysis of the MBP fusion as an alternative to post-purification proteolysis; (4) the effect of the level of LacI repressor on the yields of protein obtained from E. coli using autoinduction; (5) the consequences of removing the His tag from proteins produced by the cell-free system; and (6) the comparative performance of E. coli cells or wheat germ cell-free translation. Optimal promoter/repressor and fusion tag configurations for each expression system are discussed.

Indexed as

Cell-Free SystemCloning, MolecularEscherichia coliEukaryotaGene ExpressionGenetic VectorsGerm CellsProtein BiosynthesisProteinsTriticumProteins

Identifiers

PMID25854603
PMCPMC4430420
OpenAlexW1971229487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.